1st Quarter - Report

AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS for AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS

Firm
Client
Income
—
Expenses
$751,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Insurance INS

Healthy Mothers and Healthy Babies Access to Care Act: enact a "stacked cap" on all liability payments awarded to medical liability suits against ob/gynocologists. Medical Care Access Protection Act of 2009 Prompt Paymnet Improvement Act of 2009

LobbyistCovered position, as disclosed
JERONE DINKINS —
CHRISTY GILMOUR —
ROBERT JASAK —
JEANIE KENNEDY —
DAVID LOVETT —
ALANNA PORTER New Legislative Director for Jon Porter (R-NV)
ERIN RANSFORD —
JACQUELINE ROCHE —
WINIFRED STRZELECKI New —
CYNTHIA SYKES —
KATRINA WALLACE —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

H.R. 1829 - Medicare Patient Access to Physical Therapists Act of 2009: prevent direct access to physical therapists in order to avoid unnecessary and overuse of therapy services. H.R. 1031 - Health Information Technology Act of 2009: ensure investments in health to produce interoperable and compatible systems/programs. American Recovery & Reinvestment Act (ARRA) Practice Expense Payment Under Medicare: ensure awareness for the rising cost of practice expenses and the levels paid through Medicare. Payment of Teaching Physicians Under Medicare: ensure that physicians who teach future healers are adequately reimbursed. Payment of Graduate Medical Education Under Medicare: promote ample/adequate federal assistance to individuals enrolled in medical school who can afford the cost. Stark II - Physician Ban on Self-Referral and Other Fraud & Abuse: ensure that Stark laws do not prevent timely access to quality medical services.

LobbyistCovered position, as disclosed
JERONE DINKINS —
CHRISTY GILMOUR —
ROBERT JASAK —
JEANIE KENNEDY —
DAVID LOVETT —
ALANNA PORTER New Legislative Director for Jon Porter (R-NV)
ERIN RANSFORD —
JACQUELINE ROCHE —
WINIFRED STRZELECKI New —
CYNTHIA SYKES —
KATRINA WALLACE —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA)

Bills named: H.R. 1031 (111th), H.R. 1829 (111th)

Health Issues HCR

H.R. 1678 - Mitigating the Impact of Uncompensated Service and Time Act of 2009 Health Americans Act H.R. 1021 - Access to America's Orthopedic Services Act of 2009: Musculoskeleltal Disease and Condition Legislation.

LobbyistCovered position, as disclosed
JERONE DINKINS —
CHRISTY GILMOUR —
ROBERT JASAK —
JEANIE KENNEDY —
DAVID LOVETT —
ALANNA PORTER New Legislative Director for Jon Porter (R-NV)
ERIN RANSFORD —
JACQUELINE ROCHE —
WINIFRED STRZELECKI New —
CYNTHIA SYKES —
KATRINA WALLACE —

Contacted: HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1678 (111th), H.R. 1021 (111th)

Labor Issues/Antitrust/Workplace LBR

H.R. 1493 - Quality Health Care Coalition Act of 2009: Ensure patient access to quality health care by exempting health care professionals from the Federal antitrust laws in their negotiations with health plans and health insurance issuers.

LobbyistCovered position, as disclosed
JERONE DINKINS —
CHRISTY GILMOUR —
ROBERT JASAK —
JEANIE KENNEDY —
DAVID LOVETT —
ALANNA PORTER New Legislative Director for Jon Porter (R-NV)
ERIN RANSFORD —
JACQUELINE ROCHE —
WINIFRED STRZELECKI New —
CYNTHIA SYKES —
KATRINA WALLACE —

Contacted: Medicare Payment Advisory Commission (MedPAC); SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1493 (111th)

Science/Technology SCI

Food and Drug Revitalization Act: to provide for reasonable limits for conflicts of interest on FDA advisory committees and to stimulate pediatric device development. Also, to include unique device identification systems for medical devices. H.R. 1356/S.540 - Medical Device Safety Act of 2009: to amend the Food, Drug and Cosmetic Act with respect to liability under state and local requirements for medical devices. H.R. 759 - The Food and Drug Administration Globalization Act of 2009: to provide for the safety of medical devices manufactured in foreign countries. H.R. 1548 - Pathway for Biosimilars Act: provides a pathway for the FDA approval of complex biological products from a reference product. H.R. 1427 - Promoting Innovation and Access Life-Saving Medicare Act: establishes a pathway for the FDA to approve more affordable copies of biotech and establish user fees for these products.

LobbyistCovered position, as disclosed
JERONE DINKINS —
CHRISTY GILMOUR —
ROBERT JASAK —
JEANIE KENNEDY —
DAVID LOVETT —
ALANNA PORTER New Legislative Director for Jon Porter (R-NV)
ERIN RANSFORD —
JACQUELINE ROCHE —
WINIFRED STRZELECKI New —
CYNTHIA SYKES —
KATRINA WALLACE —

Contacted: SENATE; Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 759 (111th), S. 540 (111th), H.R. 1356 (111th), H.R. 1427 (111th), H.R. 1548 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.